The life sciences part of health care isn't just drugmakers and medical device companies—data and evidence coming from life sciences is critical to the entire health care ecosystem. In this episode, Rachel Woods sits down with Advisory Board's Solomon Banjo and Pam Divack, and SVP of Optum Life Sciences Lou Brooks, to talk about the evolving role of evidence and how evidence impacts all parts of the health care ecosystem.
- What is changing life sciences market dynamics in 2022?
- [Webinar] The evolving market for real-world evidence
- The top customer trends that life sciences leaders need to know about in 2022
- To explore Advisory Board's latest thinking on the future of value-based care, visit advisory.com/VBC.
Get the Daily Briefing newsletter in your inbox. Subscribe now.